Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
That's not true at all Nightmarewalking. If you must know the story of my portfolio in recent weeks then I can give you the facts. You could just ask why I sold at a loss rather than guess.
I was holding ARB and DDDD alongside each other. I sold DDDD for a loss yes (around 6% loss) - to buy RMM which is up around 20% since I bought my shares, was 25% until the dip. I sold some ARB at a loss to reduce my exposure to crypto and put the money into DDDD at a lower price than I sold for (about 7% less). Meanwhile ARB is currently lower than I sold the loss for. So I think I have done quite well out of it.
I want to reduce my exposure to crypto further as it was a mistake to put as much into it as I did (it was 21% of my portfolio before the reduction). And yes that might mean selling more ARB at a loss. Feel free to attack me for it when I do however. I think the company is over valued based on hype and I bought in too high.
What I wanted to do was take money out of ARB for RMM but ARB was tanking at the time and I figured it would rebound. Meanwhile DDDD was flat so I figured I may as well "borrow" the money from there and put the ARB cash there once I could get out. Certainly worked out better than selling ARB for a 30% loss just to avoid people like you accusing me of trading DDDD. I could have waited to invest in RMM but I didn't want to miss price rises during the re-rate.
Sometimes you have to make tough decisions for your portfolio. Holding losses is no good if you think they will turn into bigger losses. I don't regret any sale I've made recently.
just added at 1.04
Makes no sense at all, not seen any news and it's off 5+% today. Just added
This drop makes no sense. I thought I was getting a great price at 110p the past couple of days. I wish I could add more at this price.
HOLD or BUY, yes I would agree but, self-evidently, others are not convinced! ;0)
Just wish I had some more cash.
Topped up just now at 103!!! Crazy times..... HOLD or BUY
This is no "lifestyle" company - the CEO & CSO get paid £100k a year, yet they've just invested a further £700k EACH at £1.10, to add to their significant shareholding. We've had an initial Phase II oncology readout showing clinically meaningful results in 5 out of 12 patients - some of the tumour reductions are frankly incredible, given the late stage disease progression they were at - and this trial has been expanded to sites across the US, with a US listing in place. Merck have just increased their shareholding, a partnership with Pfizer has been set up, and then they have trials progressing for asthma, IBS, arthritis etc. Why anyone would sell up now is completely beyond me. There is no way Alex and Duncan would have invested these sorts of sums if they were not absolutely convinced of the news flow to come.